BRAINLIFE.ORG
|
|
|
|
|
Neuro-Oncology
Reviews
|
|
|
|
Volume
26 Number 9
15 May 2024
|
|
|
|
Home
>
Publications
>
Neuro-Oncology
Reviews >
Volume
26, Year 2024 >
Number 9, 15 May
|
|
|
|
|
|
Morello
A, Bianconi A, Rizzo F, Bellomo J, Meyer AC, Garbossa D, Regli L,
Cofano F.
Laser
Interstitial Thermotherapy (LITT) in Recurrent Glioblastoma: What
Window of Opportunity for This Treatment?
Technol
Cancer Res Treat.
2024 May 2;23:15330338241249026. doi:
10.1177/15330338241249026. PMID:
38693845. Review. ˍ
|
|
|
|
Ser MH, Webb MJ, Sener U, Campian JL.
Immune
Checkpoint Inhibitors and Glioblastoma: A Review on Current State
and Future Directions.
J
Immunother Precis Oncol. 2024 May 2;7(2):97-110. doi:
10.36401/JIPO-23-34. PMID:
38721406.
Review. ˍ
|
|
|
|
Akdemir EY, Odia Y, Hall MD, Mehta MP, Kotecha R.
An
Update on H3K27M-altered Diffuse Midline Glioma: Diagnostic and
Therapeutic Challenges in Clinical Practice.
Pract
Radiat Oncol. 2024 May 3:S1879-8500(24)00094-8. doi:
10.1016/j.prro.2024.04.013. PMID:
38704025. Guidelines˰ ˍ
|
|
|
|
Arfuso M, Kuril S, Shah H, Hanson D.
Pediatric
Neuroglial Tumors: A Review of Ependymoma and Dysembryoplastic
Neuroepithelial Tumor.
Pediatr
Neurol. 2024 May 3;156:139-146. doi:
10.1016/j.pediatrneurol.2024.04.022. PMID:
38781722. Review˰ ˍ
|
|
|
|
Chesney KM, Keating GF, Patel N, Kilburn L, Fonseca A, Wu CC,
Nazarian J, Packer RJ, Donoho DA, Oluigbo C, Myseros JS, Keating
RF, Syed HR.
The role of focused
ultrasound for pediatric brain tumors: current insights and future
implications on treatment strategies.
Childs
Nerv Syst. 2024 May 3. doi:
10.1007/s00381-024-06413-9. PMID:
38702518. Review˰ ˍ
|
|
|
|
Chou SC, Chen YN, Huang HY, Kuo MF, Wong TT, Kuo SH, Yang
SH.
Contemporary Management of
Pediatric Brainstem Tumors.
Adv
Tech Stand Neurosurg. 2024 May 4;49:231-254. doi:
10.1007/978-3-031-42398-7_11. PMID:
38700687. Review; Book chapter˰
ˍ
|
|
|
|
Kotch C, de Blank P, Gutmann DH, Fisher MJ.
Low-grade
glioma in children with neurofibromatosis type 1: surveillance,
treatment indications, management, and future directions.
Childs
Nerv Syst. 2024 May 5. doi:
10.1007/s00381-024-06430-8. PMID:
38704493. Review˰ ˍ
|
|
|
|
Hu Z, Ye J, Shi S, Luo C, Wang T, Liu Y, Ye J, Sun X, Ke Y, Hou
C.
Maternal smoking, consumption of
alcohol, and caffeinated beverages during pregnancy and the risk
of childhood brain tumors: a meta-analysis of observational
studies.
BMC
Public Health. 2024 May 6;24(1):1238. doi:
10.1186/s12889-024-18569-9. PMID:
38711042. Meta-analysis. ˍ
|
|
|
|
Xu C, Hou P, Li X, Xiao M, Zhang Z, Li Z, Xu J, Liu G, Tan Y, Fang
C.
Comprehensive understanding of
glioblastoma molecular phenotypes: classification,
characteristics, and transition.
Cancer
Biol Med. 2024 May 6:j.issn.2095-3941.2023.0510. doi:
10.20892/j.issn.2095-3941.2023.0510. PMID:
38712813. Review.
ˍ
|
|
|
|
de Zwart B, Ruis C.
An update on tests
used for intraoperative monitoring of cognition during awake
craniotomy.
Acta
Neurochir (Wien). 2024 May 7;166(1):204. doi:
10.1007/s00701-024-06062-6. PMID:
38713405. Review.
ˍ
|
|
|
|
Ghaznavi H, Afzalipour R, Khoei S, Sargazi S, Shirvalilou S,
Sheervalilou R.
New insights into
targeted therapy of glioblastoma using smart nanoparticles.
Cancer
Cell Int. 2024 May 7;24(1):160. doi:
10.1186/s12935-024-03331-3. PMID:
38715021. Review.
ˍ
|
|
|
|
Lan J, Liu Y, Chen J, Liu H, Feng Y, Liu J, Chen L.
Advanced
tumor electric fields therapy: A review of innovative research and
development and prospect of application in glioblastoma.
CNS
Neurosci Ther. 2024 May 7;30(5):e14720. doi:
10.1111/cns.14720. PMID:
38715344.
Review. ˍ
|
|
|
|
Lin C, Smith C, Rutka J.
Current
immunotherapeutic approaches to diffuse intrinsic pontine glioma.
Front Genet. 2024 May 7;15:1349612. doi:
10.3389/fgene.2024.1349612. PMID:
38774284. Review. ˍ
|
|
|
|
Solomou G, Young AMH, Bulstrode HJCJ.
Microglia
and macrophages in glioblastoma: landscapes and treatment
directions.
Mol
Oncol. 2024 May 7. doi:
10.1002/1878-0261.13657. PMID:
38712663. Review.
ˍ
|
|
|
|
Wu
J, Zhou Z, Wu Z, Tang Z, Li M, Yin S, Luo X, Wang L, Chen Y, Zhao
G, Jiang T, Mao Y; National Glioma MDT Alliance of National Center
for Neurological Diseases.
Consensuses
of Chinese experts on Glioma multidisciplinary team management
(2nd edition).
Chin
Med J (Engl).
2024 May 7. doi:
10.1097/CM9.0000000000003129. PMID:
38712913. Guidelines. ˍ
|
|
|
|
Lin H, Liu C, Hu A, Zhang D, Yang H, Mao Y.
Understanding
the immunosuppressive microenvironment of glioma: mechanistic
insights and clinical perspectives.
J
Hematol Oncol. 2024 May 8;17(1):31. doi:
10.1186/s13045-024-01544-7. PMID:
38720342. Review.
ˍ
|
|
|
|
Meena D, Jha S.
Autophagy in
glioblastoma: A mechanistic perspective.
Int
J Cancer. 2024 May 8. doi:
10.1002/ijc.34991. PMID:
38716809. Review˰
ˍ
|
|
|
|
Young
CM, Viña-González A, de Toledo Aguiar RS, Kalman C,
Pilitsis JG, Martin-Lopez LI, Mahani T, Pineda-Pardo JA.
A
Scoping Review of Focused Ultrasound Enhanced Drug Delivery for
Across the Blood-Brain Barrier for Brain Tumors.
Oper
Neurosurg (Hagerstown).
2024 May 8. doi:
10.1227/ons.0000000000001175. PMID:
38717167.Review˰ ˍ
|
|
|
|
Bugakova AS, Chudakova DA, Myzina MS, Yanysheva EP, Ozerskaya IV,
Soboleva AV, Baklaushev VP, Yusubalieva GM.
Non-Tumor
Cells within the Tumor Microenvironment-The "Eminence Grise"
of the Glioblastoma Pathogenesis and Potential Targets for
Therapy.
Cells.
2024 May 9;13(10):808. doi:
10.3390/cells13100808. PMID:
38786032. Review. ˍ
|
|
|
|
*Lerouge L, Ruch A, Pierson J, Thomas N, Barberi-Heyob M.
Non-targeted effects of radiation
therapy for glioblastoma.
Heliyon.
2024 May 9;10(10):e30813. doi:
10.1016/j.heliyon.2024.e30813. PMID:
38778925. Review. ˍ
|
|
|
|
No
authors listed.
Glioma.
Nat
Rev Dis Primers.
2024 May 9;10(1):34. doi:
10.1038/s41572-024-00524-y. PMID:
38724549. Primer. ˍ
|
|
|
|
Schaff LR, Ioannou M, Geurts M, van den Bent MJ, Mellinghoff IK,
Schreck KC.
State of the Art in
Low-Grade Glioma Management: Insights From Isocitrate
Dehydrogenase and Beyond.
Am
Soc Clin Oncol Educ Book. 2024 May 9;44(3):e431450.
doi:
10.1200/EDBK_431450. PMID:
38723228. Review. ˍ
|
|
|
|
Weller M, Wen PY, Chang SM, Dirven L, Lim M, Monje M, Reifenberger
G.
Glioma.
Nat
Rev Dis Primers. 2024 May 9;10(1):33. doi:
10.1038/s41572-024-00516-y. PMID:
38724526. Review˰
ˍ
|
|
|
|
Zedde
M, Grisendi I, Assenza F, Napoli M, Moratti C, Di Cecco G, Pavone
C, Bonacini L, D'Aniello S, Pezzella FR, Romano A, Pavesi G,
Valzania F, Pascarella R.
Cerebellar
mutism syndrome caused by bilateral cerebellar hemorrhage in
adults: a case report and review of the literature.
Neurol
Sci.
2024 May 9. doi:
10.1007/s10072-024-07571-z. PMID:
38724752. Case report; Review˰ ˍ
|
|
|
|
Koizumi S, Oishi T, Iwaizumi M, Kurozumi K.
Genomic
medicine advances for brain tumors.
Int
J Clin Oncol. 2024 May 10. doi:
10.1007/s10147-024-02522-2. PMID:
38727852. Review˰
ˍ
|
|
|
|
Mandorino M, Maitra A, Armenise D, Baldelli OM, Miciaccia M,
Ferorelli S, Perrone MG, Scilimati A.
Pediatric
Diffuse Midline Glioma H3K27-Altered: From Developmental Origins
to Therapeutic Challenges.
Cancers
(Basel). 2024 May 10;16(10):1814. doi:
10.3390/cancers16101814. PMID:
38791893. Review. ˍ
|
|
|
|
Montes-Escobar K, de la Hoz-M J, Castillo-Cordova P, Duran-Ospina
JP, Bravo-Saltos RK, Lapo-Talledo GJ, Siteneski A.
Glioblastoma:
a comprehensive approach combining bibliometric analysis, Latent
Dirichlet Allocation, and HJ-Biplot : Glioblastoma insights and
trends: a 49-year bibliometric analysis.
Neurosurg
Rev. 2024 May 10;47(1):209. doi:
10.1007/s10143-024-02440-x. PMID:
38724684. Bibliometric analysis˰
ˍ
|
|
|
|
Wassef
CE, Cain SA, Drummond KJ.
Changing
practice to improve quality of life in glioma.
J
Neurosurg.
2024 May 10:1-11. doi:
10.3171/2024.2.JNS221799. PMID:
38728762. Review˰ ˍ
|
|
|
|
Das S, Ahlawat S, Panda AK, Sarangi J, Jain P, Gupta RK, Vaishya
S, Patir R.
Pediatric high grade
gliomas: A comprehensive histopathological, immunohistochemical
and molecular integrated approach in routine practice.
Pathol
Res Pract. 2024 May 11;258:155347. doi:
10.1016/j.prp.2024.155347. PMID:
38763090. Review˰ ˍ
|
|
|
|
Habibi MA, Rashidi F, Gharedaghi H, Arshadi MR, Kazemivand S.
The
safety and efficacy of bevacizumab in treatment of recurrent
low-grade glioma: a systematic review and meta-analysis.
Eur
J Clin Pharmacol. 2024 May 11. doi:
10.1007/s00228-024-03695-5. PMID:
38733390. Review; Meta-analysis˰
ˍ
|
|
|
|
Jensen MP, Qiang Z, Khan DZ, Stoyanov D, Baldeweg SE, Jaunmuktane
Z, Brandner S, Marcus HJ.
Artificial
intelligence in histopathological image analysis of central
nervous system tumours: A systematic review.
Neuropathol
Appl Neurobiol. 2024 May 13;50(3):e12981. doi:
10.1111/nan.12981. PMID:
38738494. Review; Recommendations. ˍ
|
|
|
|
Afshari AR, Sanati M, Ahmadi SS, Kesharwani P, Sahebkar A.
Harnessing the capacity of
phytochemicals to enhance immune checkpoint inhibitor therapy of
cancers: A focus on brain malignancies.
Cancer
Lett. 2024 May 14;593:216955. doi:
10.1016/j.canlet.2024.216955. PMID:
38750720. Review˰ ˍ
|
|
|
|
Cela I, Capone E, Trevisi G, Sala G.
Extracellular
vesicles in glioblastoma: Biomarkers and therapeutic tools.
Semin
Cancer Biol. 2024 May 14;101:25-43. doi:
10.1016/j.semcancer.2024.04.003. PMID:
38754752. Review. ˍ
|
|
|
|
Liu YT, Chen YH, Chang CH, Liang HT.
Recurrent
fibroblast growth factor receptor3 fusion glioblastoma treated
with pemigatinib: A case report and review of the literature.
Neurooncol
Adv. 2024 May 14;6(1):vdae072. doi:
10.1093/noajnl/vdae072. PMID:
38845691. Case report; Review. ˍ
|
|
|
|
O'Hare P, Cooney T, de Blank P, Gutmann DH, Kieran M, Milde T,
Fangusaro J, Fisher M, Avula S, Packer R, Fukuoka K, Mankad K,
Mueller S, Waanders AJ, Opocher E, Bouffet E, Raabe E, Werle NE,
Azizi AA, Robison NJ, Hernáiz Driever P, Russo M, Schouten
N, van Tilburg CM, Sehested A, Grill J, Bandopadhayay P, Kilday
JP, Witt O, Ashley DM, Ertl-Wagner BB, Tabori U, Hargrave
DR.
Resistance, rebound, and recurrence
regrowth patterns in pediatric low-grade glioma treated by MAPK
inhibition: A modified Delphi approach to build international
consensus-based definitions-International Pediatric Low-Grade
Glioma Coalition.
Neuro
Oncol. 2024 May 14:noae074. doi:
10.1093/neuonc/noae074. PMID:
38743009. Guidelines. ˍ
|
|
|
|
Nwafor DC, Obiri-Yeboah D, Fazad F, Blanks W, Mut M.
Focused
ultrasound as a treatment modality for gliomas.
Front
Neurol. 2024 May 15;15:1387986. doi:
10.3389/fneur.2024.1387986. PMID:
38813245. Review. ˍ
|
|
|
|
Sanders
JJ, Temin S, Ghoshal A, Alesi ER, Ali ZV, Chauhan C, Cleary JF,
Epstein AS, Firn JI, Jones JA, Litzow MR, Lundquist D, Mardones
MA, Nipp RD, Rabow MW, Rosa WE, Zimmermann C, Ferrell BR.
Palliative
Care for Patients With Cancer: ASCO Guideline Update.
J
Clin Oncol.
2024 May 15;42(19):2336-2357. doi:
10.1200/JCO.24.00542. PMID:
38748941. Guidelines. ˍ
|
|
|
|
Simon M, Hagemann A, Gajadin S, Signorelli F, Vincent AJPE; EANS
Neuro-oncology Section.
Surgical
treatment for insular gliomas. A systematic review and
meta-analysis on behalf of the EANS neuro-oncology section.
Brain
Spine. 2024 May 15;4:102828. doi:
10.1016/j.bas.2024.102828. PMID:
38859917. Review; Meta-analysis. ˍ
|
|
|
|
|
|
|
|
|
|
|
***
|
|